GHK-Cu does not appear to have hormonal effects, carcinogenic potential, or genotoxic properties based on available research
So the peptide is not just present it is active in processes people actually care about when they are trying to look better, heal better, or age a little less visibly
As previously discussed, Dravet Syndrome (DS) is an NDD caused by haploinsufficiency of the SCN1A voltage-gated Na 2+ channel [72, 109]
Advanced recovery, peptide therapy For patients who want faster healing, reduced inflammation, and improved recovery
Administration routes Different peptides favor different administration routes, and the choice can significantly affect both bioavailability and the distribution of effects throughout the body
Similarly, Brigham Buhler of Ways2Well claims to have put 75,000+ patients on peptides, across their practices, with no reported adverse events